Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation

Inclusion Criteria: * Subject must have a visually significant age-related cataract, in the planned operated eye. * 18 years of age or older. * The vision in the fellow, unoperated eye should have a potential visual acuity of 20/40 or better as determined by the principal investigator. * Patient must desire cataract extraction. * Willing and able to comply with scheduled visits and other study procedures. Exclusion Criteria: * Advanced glaucomatous damage. * Any abnormality preventing reliable applanation tonometry in operated eye. * Contact lens use during the active treatment portion of the trial in the operated eye. * Any concurrent infectious/non infectious conjunctivitis, keratitis or uveitis in either eye. * Any history of allergic hypersensitivity or poor tolerance to any component of the preparations used in this trial. * Pregnant or nursing mothers and females of childbearing potential not practicing a reliable and medically acceptable method of birth control. * Any clinically significant, serious or severe medical or psychiatric condition. * Participation in (or current participation) any investigational drug or device trial within the previous 30 days prior to the start date of this trial. * Intraocular conventional surgery within the past three months or intraocular laser surgery within one month in the operated eye. * Required use of other topical medications during the active portion of the trial except prophylactic antibiotic, topical lid care, tear replacement solutions or glaucoma medications. * Other ocular surgery at the time of the cataract extraction. * Use of topical or oral antiprostaglandins or corticosteroids as well as aspirin products (\> 81 mg) during the active treatment portion of the trial. If patient wants to participate in the trial and can stop the medication, he/she can be enrolled after 7-day wash out period.